| 发明名称 |
A sustained -release composition containing a melanocortin receptor ligand as the active ingredient |
| 摘要 |
The present invention relates to a sustained-release drug composition consisting essentially of microparticies of a peptide as the active substance and a biocompatible water-soluble polymer, in particular peptide as meianocortin receptor ligand. The present invention relates also to an injection formulation comprising the sustained-release drug composition suspended in an injection medium. |
| 申请公布号 |
AU2012270024(B2) |
申请公布日期 |
2016.12.22 |
| 申请号 |
AU20120270024 |
申请日期 |
2012.06.13 |
| 申请人 |
Ipsen Pharma S.A.S. |
发明人 |
Richard, Joel;Laredj, Faiza;Baronnet, Marie-Madeleine;Nourrisson, Didier;Harnett, Jeremiah;Hacher, Beatrice;Mondoly, Nathalie;Bertocchi, Laurent |
| 分类号 |
A61K9/16;A61K9/00;A61K38/33;A61K38/35;A61K47/36 |
主分类号 |
A61K9/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
